Adapted from Chi KN, et al. 2021.
Click below to find out more about the clinical benefits with ERLEADA® + ADT:
ADT, androgen deprivation therapy. ALP, alkaline phosphatase level. CI, confidence interval. EU, European Union. HR, hazard ratio. ECOG, Eastern Cooperative Oncology Group. LDH, lactate dehydrogenase. M1, metastasised outside the pelvis. mHSPC, metastatic hormone-sensitive prostate cancer. NA, not available. NR, not reported. OS, overall survival. PSA, prostate-specific antigen. QoL, quality of life. ULN, upper limit of normal.
Para visualizar o IECRCM de Erleada®, veja aqui.